Bovine ELISA
Brucella-Ab indirect
Brucella-Ab competitive
Brucella-Ab competitive
Porcine ELISA
L.intracellularis / Ileitis-Ab
Brucella-Ab competitive
Equine ELISA
EHV1/EHV4-Ab
From April 1st 2021, Svanova is part of INDICAL (www.indical.com). At INDICAL, our purpose is to help prevent, monitor, and eradicate animal diseases through improved diagnostic technologies. INDICAL focuses on complete solutions for molecular and immunological veterinary testing.
Our veterinary-specific sample prep technologies, PCR assays and reagents, ELISA kits, and instruments are relied upon by veterinarians, industry, and government agencies worldwide for the identification of animal diseases, such as Avian Influenza, Bovine Viral Diarrhea and African Swine Fever.
Svanova arose out of activities in the Swedish Veterinary Institute (SVA) where veterinary diagnostic solutions for eradication programs and disease monitoring were pioneered – test kits to detect antibodies against virus, bacteria, parasites and mycoplasmas in various animal species, but with the main focus on Bovine and Porcine.
In the beginning the kits were predominantly used in Sweden, but the demand for quality diagnostic solutions grew beyond the borders of Sweden and Scandinavia and gradually expanded globally.
Svanova Biotech AB is formed
The business developed rapidly and in 2001 it was decided to move the activities into a separate business outside the Veterinary Institute. The company Svanova Biotech AB was formed.
Svanova Biotech AB retained the tradition of developing new diagnostic solutions based on thorough knowledge in the field of infectious diseases in production animals. Also a large global network in the veterinary research community, a customer focused approach and not ever compromising quality of the products and services to the market, characterize the company.
Global player
The SVANOVIR® products from Svanova have since 2003 been developed, manufactured and supplied to the market according to the ISO 9001:2015 quality management system.
Today the portfolio comprises over 25 different ELISAs and is supplied to more than 70 countries worldwide.